OsteoMove Extra Strength Joint Care
On sale on the US market (according to the DSLD)
Natural Factors, food supplement from the US market
OsteoMove Extra Strength Joint Care (Natural Factors), a food supplement au code-barres 068958268415, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Potassium: up to 260 mg a day according to the label (at most 1 serving a day), above the maximum dose of 80 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Natural Factors
- Barcode
- 068958268415
- Form
- Tablet
- One serving
- 2 tablets
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Croscarmellose Sodium, Hydroxypropyl Cellulose, Microcrystalline Cellulose, Modified Cellulose, Maltodextrin, Medium Chain Triglycerides, Magnesium Stearate
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Manganese | Mineral | 1.5 mg |
| Sodium | Mineral | 35 mg |
| Potassium | Mineral | 260 mg |
| Glucosamine Sulfate | Other substance | 1,500 mg |
| OptiMSM | Other substance | 600 mg |
| Chondroitin Sulfate | Other substance | 400 mg |
| OsteoMove Ultra Fruit Polyphenol Complex | Blend | 200 mg |
| Grape seed extract | Plant | not stated |
| Blueberry | Plant | not stated |
| Bilberry | Plant | not stated |
| Cranberry | Plant | not stated |
| Pomegranate (Punica granatum) | Plant | not stated |
| Raspberry | Plant | not stated |
| Strawberry | Plant | not stated |
| Polyphenols | Other substance | 152 mg |
| Boswellia (Boswellia serrata) extract | Plant | 100 mg |
| Boswellic Acids | Other substance | 60 mg |
| Turmeric (Curcuma longa) extract (Curcuma longa) | Plant | 30 mg |
| providing Curcuminoids | Other substance | 28.5 mg |
| Hydrolyzed Collagen Type II | Protein | 15 mg |
| Hyaluronic Acid | Other substance | 15 mg |
| Boron | Mineral | 450 µg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: OsteoMove Extra Strength
Entered into DSLD on 22 May 2015. Withdrawn from the US market on 19 September 2014 (according to the DSLD).- Active ingredient added : Collagen Type II (15 mg)
- Active ingredient added : Hyabest Hyaluronic Acid (15 mg)
- Active ingredient removed : Hyaluronic Acid (15 mg)
- Active ingredient removed : Hydrolyzed Collagen Type II (15 mg)
- Active ingredient removed : Potassium (260 mg)
- Same quantity, different name: MSM in this version; OptiMSM on the displayed label (600 mg)
- Different quantity per serving : Sodium: 60 mg in this version; 35 mg on the displayed label
Official label: OsteoMove Extra Strength
Entered into DSLD on 10 October 2014. Withdrawn from the US market on 10 February 2022 (according to the DSLD).- Active ingredient removed : Potassium (260 mg)
- Same quantity, different name: Hyabest Hyaluronic Acid in this version; Hyaluronic Acid on the displayed label (15 mg)
- Same quantity, different name: MSM in this version; OptiMSM on the displayed label (600 mg)
- Different quantity per serving : Sodium: 60 mg in this version; 35 mg on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Pomegranate
Read the warning, when it applies and the studies cited
- Turmeric (Curcuma longa) extract
Read the warning, when it applies and the studies cited
TURMERIC - CURCUMA LONGA - Oral
Route of administration: Oral (ESCOP 2003; Blumenthal et al. 2000)
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (ESCOP 2003; Brinker 2001; McGuffin et al. 1997).
Sources cited by Health Canada (2)
- ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder (HC 2025; EMA 2018; Brinker 2010; ESCOP 2003; McGuffin et al. 1997).
Sources cited by Health Canada (6)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2018. European Medicines Agency. European Union herbal monograph on Curcuma longa L., rhizome. London (GB): EMA Committee on Herbal Medicinal Products (HMPC); 25 September 2018. [Accessed 2023 October 14] Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-curcuma-longa-l-rhizoma-revision-1_en.pdf
- ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).
Sources cited by Health Canada (2)
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).
Sources cited by Health Canada (2)
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Condition of application: All uses except for Source of antioxidants and Hepatoprotectant.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 26 September 2025
Turmeric -CURCUMA LONGA - Topical
Cautions and warnings
For external use only.
When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Contraindications
Do not use on deep or puncture wounds, animal bites or serious burns.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Natural Factors
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “OsteoMove Extra Strength Joint Care (Natural Factors): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/68958268415-osteomove-extra-strength-joint-care-natural-factors, updated 23 January 2023.